Finally, the evaluation indicators of the clinical treatment effect of breast cancer include survival rate, recurrence rate, remission rate, etc. Among them, the pathological complete remission rate PCR is an important indicator to measure the effect of NAT treatment. The gene discussed is BRD2; the disease is breast carcinoma.